Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas
暂无分享,去创建一个
G. Snow | P. Snijders | L. Smeele | R. Brakenhoff | M. V. D. van den Brekel | C. Meijer | J. Kummer | F. Denkers | V. V. van Houten | B. van Leeuwen
[1] C. McNeil. HPV in oropharyngeal cancers: new data inspire hope for vaccines. , 2000, Journal of the National Cancer Institute.
[2] D. Sidransky,et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.
[3] C. Ostwald,et al. p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study. , 1997, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[4] C. Meijer,et al. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. , 1998, Cancer research.
[5] J. Walboomers,et al. Prevalence of mucosotropic human papillomaviruses in squamous‐cell carcinomas of the head and neck , 1996, International journal of cancer.
[6] J. Walboomers,et al. p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck , 1997, International journal of cancer.
[7] A. Levine,et al. Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.
[8] C. Meijer,et al. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings , 1997, Journal of clinical microbiology.
[9] Arnold J. Levine,et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.
[10] S. Schwartz,et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. , 1998, Journal of the National Cancer Institute.
[11] Carl W. Miller,et al. Mutations of p53 and human papillomavirus infection in cervical carcinoma , 1993, Cancer.
[12] P. Green,et al. Identification of p53 gene mutations in bladder cancers and urine samples. , 1991, Science.
[13] J. Jen,et al. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[14] K. Vousden,et al. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation , 1991, Cell.
[15] S. Franceschi,et al. How strong and how wide is the link between HPV and oropharyngeal cancer? , 2000, The Lancet.
[16] C. Meijer,et al. Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. , 1994, The Journal of general virology.
[17] R. Biggar,et al. Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas , 1999, The Lancet.
[18] A. Olshan,et al. Human Papillomavirus and head and neck cancer: Epidemiology and molecular biology , 1998, Head & neck.
[19] J. Peto,et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.
[20] C. Meijer,et al. Role of human papillomaviruses in cancer of the respiratory and upper digestive tract. , 1997, Clinics in dermatology.
[21] W. Mason,et al. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours , 1992, The Lancet.
[22] S. Syrjänen,et al. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. , 1983, International journal of oral surgery.